Cargando…
Phenotypic Screening Approaches to Develop Aurora Kinase Inhibitors: Drug Discovery Perspectives
Targeting mitotic regulators as a strategy to fight cancer implies the development of drugs against key proteins, such as Aurora-A and -B. Current drugs, which target mitosis through a general mechanism of action (stabilization/destabilization of microtubules), have several side effects (neutropenia...
Autores principales: | Marugán, Carlos, Torres, Raquel, Lallena, María José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703775/ https://www.ncbi.nlm.nih.gov/pubmed/26779442 http://dx.doi.org/10.3389/fonc.2015.00299 |
Ejemplares similares
-
Aurora Kinase Inhibitors: Current Status and Outlook
por: Bavetsias, Vassilios, et al.
Publicado: (2015) -
The Discovery of Aurora Kinase Inhibitor by Multi-Docking-Based Virtual Screening
por: Kim, Jun-Tae, et al.
Publicado: (2014) -
A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors
por: de Groot, Christian O., et al.
Publicado: (2015) -
Ubiquitin-Mediated Degradation of Aurora Kinases
por: Lindon, Catherine, et al.
Publicado: (2016) -
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
por: Stefani, Alessio, et al.
Publicado: (2022)